Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MicroRNA-21-IN-1 | 2848720-31-8 | 98.0% | 548.65 g/mol | C30H37FN6O3 | 5 MG
SDP

Catalog No. 5000222139
Encompass_Preferred

microRNA-21-IN-1 is a small-molecule inhibitor of microRNA-21 (miR-21) for cellular research. It exhibits antiproliferative activity in cancer cell lines and modulates downstream functional targets of miR-21, supporting studies of miR-21 biology and anticancer mechanisms.

  • Efficient miR-21 inhibition in cellular assays.
  • Antiproliferative activity in HeLa and HCT-116 cells (IC50 5.5 μM and 2.8 μM).
  • Promotes apoptosis in HeLa cells.
  • Modulates downstream targets PTEN, EGR1, and SLIT2.
  • High purity solid suitable for research use (98.0%).
  • Available in small research pack sizes for dosing studies.

Catalog No. 50-002-22139 Supplier Medchemexpress LLC Supplier No. HY1464115MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

microRNA-21-IN-1 is a small-molecule inhibitor of microRNA-21 (miR-21) for cellular research. It exhibits antiproliferative activity in cancer cell lines and modulates downstream functional targets of miR-21, supporting studies of miR-21 biology and anticancer mechanisms.

  • Efficient miR-21 inhibition in cellular assays.
  • Antiproliferative activity in HeLa and HCT-116 cells (IC50 5.5 μM and 2.8 μM).
  • Promotes apoptosis in HeLa cells.
  • Modulates downstream targets PTEN, EGR1, and SLIT2.
  • High purity solid suitable for research use (98.0%).
  • Available in small research pack sizes for dosing studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.